Nu Skin(NUS)
Search documents
Nu Skin(NUS) - 2021 Q2 - Earnings Call Transcript
2021-08-05 01:38
Financial Data and Key Metrics Changes - Revenue increased by 15% to $704.1 million, positively impacted by 6% due to favorable foreign currency [22][24] - Earnings per share improved by 42% to $1.15, benefiting from improved gross margin and overall cost containment [22][24] - Gross margin improved by 80 basis points to 75.6%, driven by product mix, product cost focus, and supply chain efficiencies [23][24] Business Line Data and Key Metrics Changes - Beauty device systems now account for approximately 30% of total revenue, with the launch of ageLOC Boost contributing to this growth [13][14] - Nutricentials Bioadaptives performed well, targeting millennial and Gen Z consumers [13] - The company plans to introduce Beauty Focus Collagen+ and ageLOC Meta in the second half of the year, expanding its product offerings [14][50] Market Data and Key Metrics Changes - The Western segments accounted for approximately 40% of total revenue, with strong growth in the Americas-Pacific region [9][18] - EMEA market showed excitement for ageLOC Boost, with social commerce driving business growth [19] - Southeast Asia faced challenges due to COVID-19, but revenue and sales leader growth were observed in Indonesia [21] Company Strategy and Development Direction - The company aims to become a leading innovative beauty and wellness company through a dynamic affiliate opportunity platform [12][22] - Focus on social commerce and leveraging micro-influencers to build brand awareness and acquire customers [15][16] - Investment in digital tools and connected devices to enhance customer engagement and personalization [10][16] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future, highlighting the transition to a more customer-obsessed enterprise [6][9] - The company is well-positioned to leverage macro trends and shifts in consumer behavior [6][11] - Management acknowledged challenges in certain markets but remains confident in growth potential [19][21] Other Important Information - The company established aggressive sustainability goals focusing on people, product, and planet [8] - Cash from operations was $20 million, with strategic investments in inventory to meet customer demand [24] - Annual revenue guidance was raised to $2.81 billion to $2.87 billion, with EPS guidance increased by $0.20 to a range of $4.30 to $4.50 [25] Q&A Session Summary Question: What is driving the geographic mix shift out of Asia into Western markets? - Management indicated that social commerce is propelling growth in the West, while adaptation in the East is taking longer [28][29] Question: How should we think about customer numbers and retention? - Management noted that customer numbers were impacted by tough comparisons year-over-year, particularly in Southeast Asia and Argentina [34][36] Question: Can you provide insights on the data captured through the affiliate model? - Management emphasized the importance of data collection for future growth, focusing on personalization and connected devices [37][39] Question: What is driving the improvement in gross margin? - Management attributed gross margin improvements to better product costs, product mix, and supply chain efficiencies [44][46] Question: What are the expectations for ageLOC Meta's launch? - Management expects similar performance to previous product launches, estimating around $70 million in revenue between the two new products [50]
Nu Skin(NUS) - 2021 Q2 - Quarterly Report
2021-08-04 16:00
[Part I. Financial Information](index=3&type=section&id=Part%20I.%20Financial%20Information) [Financial Statements (Unaudited)](index=3&type=section&id=Item%201.%20Financial%20Statements%20(Unaudited)) Presents unaudited consolidated financial statements as of June 30, 2021, showing growth in revenue, net income, and changes in financial position [Consolidated Balance Sheets](index=3&type=section&id=Consolidated%20Balance%20Sheets) Total assets increased to $2.05 billion, driven by inventories, while liabilities and equity also grew Consolidated Balance Sheet Highlights (in thousands) | Account | June 30, 2021 | December 31, 2020 | | :--- | :--- | :--- | | **Total Assets** | **$2,049,980** | **$1,957,076** | | Cash and cash equivalents | $354,759 | $402,683 | | Inventories, net | $390,977 | $314,366 | | **Total Liabilities** | **$1,132,154** | **$1,062,805** | | Current portion of long-term debt | $152,500 | $30,000 | | **Total Stockholders' Equity** | **$917,826** | **$894,271** | [Consolidated Statements of Income](index=4&type=section&id=Consolidated%20Statements%20of%20Income) Q2 2021 revenue increased 15% to $704.1 million, with net income up 41.8% to $59.3 million Q2 & H1 2021 vs 2020 Performance (in thousands, except per share) | Metric | Q2 2021 | Q2 2020 | % Change | H1 2021 | H1 2020 | % Change | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | **Revenue** | **$704,055** | **$612,366** | **+15.0%** | **$1,381,081** | **$1,130,394** | **+22.2%** | | **Operating Income** | $85,376 | $58,074 | +47.0% | $148,289 | $94,639 | +56.7% | | **Net Income** | $59,338 | $41,851 | +41.8% | $106,768 | $61,581 | +73.4% | | **Diluted EPS** | $1.15 | $0.81 | +42.0% | $2.06 | $1.15 | +79.1% | [Consolidated Statements of Cash Flows](index=8&type=section&id=Consolidated%20Statements%20of%20Cash%20Flows) Operating cash flow sharply decreased to $1.9 million due to increased inventories and decreased accrued expenses Six Months Ended June 30 Cash Flow Summary (in thousands) | Activity | 2021 | 2020 | | :--- | :--- | :--- | | Net cash provided by operating activities | $1,859 | $166,081 | | Net cash used in investing activities | ($55,235) | ($28,489) | | Net cash provided by/(used in) financing activities | $11,233 | ($92,533) | | **Net (decrease) increase in cash** | **($47,924)** | **$39,882** | - The significant decrease in operating cash flow was largely driven by an **$80.2 million** increase in inventories and a **$55.4 million** decrease in accrued expenses[29](index=29&type=chunk) [Notes to Consolidated Financial Statements](index=9&type=section&id=Notes%20to%20Consolidated%20Financial%20Statements) Details accounting policies, segment performance, debt, capital stock, and the MyFavoriteThings acquisition - The company reports revenue across ten segments: seven geographic Nu Skin segments and three Rhyz Investments segments (Manufacturing, Grow Tech, Rhyz other)[31](index=31&type=chunk)[76](index=76&type=chunk) - As of June 30, 2021, the company had **$322.5 million** outstanding on its term loan and **$120.0 million** on its revolving credit facility[43](index=43&type=chunk) - During the first six months of 2021, the company repurchased **1.2 million shares** for **$60.4 million** $265.4 million remained available for repurchases as of June 30, 2021[52](index=52&type=chunk) - In April 2021, the company acquired MyFavoriteThings, Inc. for **$16.8 million** in cash, with potential for an additional **$24.0 million** in contingent consideration This resulted in **$12.6 million** of goodwill[89](index=89&type=chunk) [Management's Discussion and Analysis (MD&A)](index=20&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Q2 revenue grew 15% due to digital-first strategy, with EPS up 42%, despite decreased operating cash flow - Q2 2021 revenue increased **15%** to **$704.1 million**, benefiting from a **6%** positive impact from foreign currency fluctuations Sales Leaders grew **15%** while Customers decreased **2%** year-over-year[93](index=93&type=chunk) - The business continues to benefit from a strategic shift to digital and social commerce, which has been more broadly adopted in the Americas/Pacific and EMEA segments, driving their growth[94](index=94&type=chunk) - The company is continuing the launch of ageLOC Boost and is preparing for the launch of Beauty Focus Collagen+ and ageLOC Meta in the second half of 2021 and into 2022[94](index=94&type=chunk) - Cash from operations for H1 2021 was only **$1.9 million**, down from **$166.1 million** in H1 2020, primarily due to an **$80.2 million** increase in inventory and higher commission/incentive payouts[123](index=123&type=chunk) [Segment Results](index=21&type=section&id=Segment%20Results) EMEA led Q2 revenue growth at 64%, with Americas/Pacific also strong, while other regions varied Q2 2021 Revenue Growth by Segment (vs Q2 2020) | Segment | Revenue (USD M) | % Change | Constant Currency % Change | | :--- | :--- | :--- | :--- | | EMEA | $83.1 | +64% | +49% | | Americas/Pacific | $151.7 | +19% | +14% | | South Korea | $88.6 | +15% | +6% | | Southeast Asia | $70.8 | +6% | +2% | | Mainland China | $154.2 | +5% | -4% | | Hong Kong/Taiwan | $38.5 | +4% | 0% | | Japan | $68.0 | 0% | +1% | - The EMEA segment's growth was boosted by the ageLOC Boost launch, which generated **$11.1 million** in sales during the quarter[109](index=109&type=chunk) - The Americas/Pacific segment's performance was negatively impacted by economic instability in Argentina, which saw a **73%** revenue decline in Q2[105](index=105&type=chunk) [Liquidity and Capital Resources](index=25&type=section&id=Liquidity%20and%20Capital%20Resources) Cash and working capital decreased, with significant cash use for operations, capex, and repurchases - Projected capital expenditures for 2021 are estimated at **$80-95 million**, including **$25-30 million** for a new manufacturing plant in Mainland China[124](index=124&type=chunk) - The company plans to refinance its Credit Agreement, which includes a term loan and revolving credit facility, within the next twelve months[124](index=124&type=chunk) - As of June 30, 2021, the company held **$321.2 million** of its cash outside the U.S The company plans to repatriate most non-U.S. earnings, except for **$60.0 million** designated as indefinitely reinvested in Mainland China[128](index=128&type=chunk)[129](index=129&type=chunk) [Quantitative and Qualitative Disclosures about Market Risk](index=28&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20about%20Market%20Risk) Primary market risk is foreign currency fluctuations, managed with swaps, impacting revenue and earnings - A majority of revenue is generated outside the U.S., making reported results sensitive to U.S. dollar exchange rate fluctuations[140](index=140&type=chunk) - The company uses interest rate swaps to hedge against interest rate movements on its variable-rate debt and may use foreign currency exchange contracts to reduce exposure to currency fluctuations[71](index=71&type=chunk)[142](index=142&type=chunk) - Highly inflationary accounting is used for the Argentina subsidiary, with the U.S. dollar as the functional currency[141](index=141&type=chunk) [Controls and Procedures](index=28&type=section&id=Item%204.%20Controls%20and%20Procedures) Disclosure controls and procedures were effective, with no material changes to internal controls - Management, including the CEO and CFO, concluded that disclosure controls and procedures were effective as of June 30, 2021[143](index=143&type=chunk) - No material changes were made to the internal control over financial reporting during the second quarter of 2021[144](index=144&type=chunk) [Part II. Other Information](index=29&type=section&id=Part%20II.%20Other%20Information) [Legal Proceedings](index=29&type=section&id=Item%201.%20Legal%20Proceedings) No material developments in legal proceedings, with no expected adverse financial impact - No material developments have occurred concerning legal proceedings discussed in the 2020 Annual Report on Form 10-K[146](index=146&type=chunk) [Risk Factors](index=29&type=section&id=Item%201A.%20Risk%20Factors) Supplements risk factors including direct selling regulations, COVID-19, economic conditions, and ESG matters - The U.S. Federal Trade Commission (FTC) is reviewing its Business Opportunity Rule If the exemption for multi-level marketing companies is removed, it could negatively impact the business[149](index=149&type=chunk) - The COVID-19 pandemic and its variants continue to pose risks by interrupting supply chains, impacting sales force activities, and potentially affecting the company's ability to comply with debt covenants[151](index=151&type=chunk)[152](index=152&type=chunk) - Difficult economic conditions, including potential inflation, could reduce consumer demand for the company's products[154](index=154&type=chunk) - Increased stakeholder focus on corporate citizenship and sustainability (ESG) matters presents a risk if the company fails to meet expectations or achieve its stated goals[155](index=155&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=31&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) Repurchased 184,723 shares at $54.16 average price in Q2 2021, with $265.4 million remaining Issuer Purchases of Equity Securities (Q2 2021) | Period | Total Shares Purchased | Average Price Paid per Share | Approx. Dollar Value Remaining (in millions) | | :--- | :--- | :--- | :--- | | April 1 - 30, 2021 | 115,209 | $52.44 | $269.4 | | May 1 - 31, 2021 | 66,299 | $56.83 | $265.6 | | June 1 - 30, 2021 | 3,215 | $60.45 | $265.4 | | **Total** | **184,723** | **$54.16** | **$265.4** | [Other Information](index=31&type=section&id=Item%205.%20Other%20Information) CFO Mark H. Lawrence's compensation adjusted, with salary increased to $575,000 and higher equity award - CFO Mark H. Lawrence's salary was increased to **$575,000**, and his 2022 annual equity award is anticipated to be approximately **$1,300,000**[160](index=160&type=chunk)
Nu Skin(NUS) - 2021 Q1 - Earnings Call Transcript
2021-05-06 02:16
Nu Skin Enterprises, Inc. (NYSE:NUS) Q1 2021 Earnings Conference Call May 5, 2021 5:00 PM ET Company Participants Scott Pond - Vice President, Investor Relations Ritch Wood - Chief Executive Officer Ryan Napierski - President and CEO-elect Mark Lawrence - Chief Financial Officer Conference Call Participants Faiza Alwy - Deutsche Bank Doug Lane - Lane Research Steph Wissink - Jefferies Mark Astrachan - Stifel Operator Good day and thank you for standing by. Welcome to the Q1 2021 Nu Skin Enterprises Earnings ...
Nu Skin(NUS) - 2021 Q1 - Earnings Call Presentation
2021-05-05 22:42
Q1 2021 Performance - Revenue increased by 31% year-over-year, with a 5.7% positive impact from foreign exchange[5] - Earnings per share (EPS) increased by 153% year-over-year to $0.91[5] - The number of sales leaders increased by 22% year-over-year[5] - The number of customers increased by 34% year-over-year[5] Customer and Sales Leader Metrics - Total customers reached 1,517,260 in Q1 2021[7] - Total sales leaders reached 60,619 in Q1 2021[7] - EMEA region saw a 111% increase in customers and an 88% increase in sales leaders[7] - Americas/Pacific region saw a 90% increase in customers and a 78% increase in sales leaders[7] Operational Performance - Gross margin was 74.8% in Q1 2021[12] - Selling expenses were 40.4% of revenue in Q1 2021[12] - General & Administrative (G&A) expenses were 25.1% of revenue in Q1 2021[12] - Operating margin was 9.3% in Q1 2021[12] 2021 Projections - The company projects 2021 EPS to be between $4.05 and $4.30, representing a 12% to 18% increase[17] - The company projects Q2 2021 revenue to be between $680 million and $705 million, representing an 11% to 15% increase, with approximately a 5% positive foreign exchange impact[17] - The company projects Q2 2021 EPS to be between $0.97 and $1.07, representing a 20% to 32% increase[17] - The company projects 2021 revenue to be between $2.80 billion and $2.87 billion, representing a 9% to 11% increase, with approximately a 3% to 4% positive foreign exchange impact[17]
Nu Skin Enterprises, Inc. (NUS) Nu Skin 2021 Investor Day (Transcript)
2021-02-12 22:33
Nu Skin Enterprises, Inc. 2021 Investor Day Summary Company Overview - **Company**: Nu Skin Enterprises, Inc. (NYSE: NUS) - **Event**: 2021 Investor Day held on February 11, 2021 Key Points and Arguments Business Resilience and Response to COVID-19 - Nu Skin faced unprecedented challenges due to the COVID-19 pandemic but demonstrated resilience and adaptability in maintaining business operations and supporting employees and sales leaders [6][11] - The management team expressed gratitude for the dedication and efforts of global employees and sales leaders during the pandemic [6][12] Leadership Transition - Ritch Wood, the current CEO, will transition the CEO role to Ryan Napierski on September 1, 2021, after 30 years with the company [8][12] - Ryan Napierski has over 25 years of experience with Nu Skin and has been prepared for this leadership role [9][12] Growth Strategy - The company aims to expand its growth strategy through innovative products, digital platforms, and a balanced geographic profile [7][21] - Nu Skin reported a 60% increase in active customer base from 980,000 in Q1 2017 to 1,560,000 in Q4 2020 [15] - The average age of customers has decreased by 5 years, attracting a younger demographic [16] Financial Performance - In Q4 2020, Nu Skin achieved its largest quarterly revenue in 7 years, with earnings per share (EPS) of $1.40, representing a 94% growth [18] - For the full year 2020, revenue grew by 7% and EPS grew by 17%, despite the pandemic [20] - The company anticipates revenue growth of 5% to 9% for 2021, equating to approximately $200 million [22] Product Innovation and Sustainability - Nu Skin introduced new products, including the ageLOC Boost device, which generated approximately $100 million in revenue in the second half of 2020 [19][41] - The company is committed to sustainability, with goals to ensure all packaging is recycled, recyclable, reusable, reduced, or renewable by 2030 [27] - Nu Skin secured 9 sustainability awards in 2020 for its waste and packaging reductions [29] Digital Transformation and Social Commerce - The company is transitioning to a digital-first affiliate marketing model, leveraging social commerce to connect with consumers [52][56] - Over 90% of revenue transactions now occur online, with approximately half coming from personal product subscriptions and loyalty programs [38] - The introduction of Vera, an AI-powered personal product recommendation tool, aims to enhance customer engagement and personalization [64] Geographic Performance - The West region, including North America and Latin America, reported record revenue growth of 53% year-over-year [67] - Mainland China showed a return to growth in Q4 2020, with active customers up 30% year-over-year [68] - Southeast Asia is beginning to adopt social commerce, with encouraging potential in markets like Indonesia and the Philippines [69] Additional Important Content - Nu Skin's commitment to corporate social responsibility (CSR) includes various initiatives, such as providing meals to children and supporting local charities [25][26] - The company emphasizes the importance of diversity, equity, and inclusion (DEI) in its workplace and community efforts [26] - Nu Skin's Empower Me strategy focuses on personalized beauty and wellness solutions, leveraging technology to enhance customer experiences [45][64] This summary encapsulates the key insights and strategic directions discussed during the Nu Skin 2021 Investor Day, highlighting the company's resilience, growth strategies, and commitment to innovation and sustainability.
Nu Skin(NUS) - 2020 Q4 - Annual Report
2021-02-10 16:00
Part I [Business](index=5&type=section&id=Item%201.%20Business) Nu Skin is a global direct selling company developing and distributing beauty and wellness solutions across approximately 50 markets, primarily through direct selling - In 2020, the company's revenue was **$2.6 billion**, with **84%** generated from outside the United States[9](index=9&type=chunk)[11](index=11&type=chunk) - Mainland China is the largest market, accounting for approximately **24%** of 2020 revenue[11](index=11&type=chunk) - The strategic investment arm, Rhyz Inc., generated **$150.2 million** (**6%** of total revenue) in 2020 from external sales, primarily from its manufacturing companies[10](index=10&type=chunk) [Products](index=5&type=section&id=PRODUCTS) The company offers personal care and wellness products under Nu Skin, Pharmanex, and ageLOC brands, emphasizing innovation and intellectual property protection Revenue by Product Category (2018-2020) | Product Category | 2020 Revenue (Millions) | 2020 % | 2019 Revenue (Millions) | 2019 % | 2018 Revenue (Millions) | 2018 % | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | Personal Care | $1,491.8 | 57.8% | $1,423.5 | 58.8% | $1,659.7 | 62.0% | | Wellness | $922.6 | 35.7% | $863.1 | 35.7% | $921.3 | 34.4% | | Other (Rhyz) | $167.5 | 6.5% | $133.8 | 5.5% | $98.0 | 3.6% | | **Total** | **$2,581.9** | **100.0%** | **$2,420.4** | **100.0%** | **$2,679.0** | **100.0%** | - ageLOC personal care products accounted for **50%** of the personal care category revenue and **29%** of total revenue in 2020[17](index=17&type=chunk) - ageLOC nutritional products accounted for **42%** of the wellness category revenue and **15%** of total revenue in 2020[18](index=18&type=chunk) - The company is launching a new beauty device system, ageLOC Boost, in the second half of 2020 and into 2021[12](index=12&type=chunk) [Distribution Channel](index=8&type=section&id=DISTRIBUTION%20CHANNEL) Nu Skin employs a direct selling channel, increasingly leveraging social commerce, with distinct models for customer and sales leader engagement, especially in Mainland China Total Customers and Sales Leaders by Region (as of year-end) | Region | Customers 2020 | Sales Leaders 2020 | Customers 2019 | Sales Leaders 2019 | Customers 2018 | Sales Leaders 2018 | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | Mainland China | 381,460 | 21,990 | 292,812 | 17,987 | 303,789 | 33,129 | | Americas/Pacific | 404,955 | 14,439 | 220,216 | 7,607 | 248,609 | 8,354 | | South Korea | 158,953 | 7,059 | 168,972 | 7,251 | 182,026 | 7,565 | | Southeast Asia | 154,355 | 8,903 | 136,349 | 7,480 | 153,465 | 8,933 | | Japan | 128,400 | 6,318 | 125,557 | 5,916 | 130,181 | 5,916 | | EMEA | 258,587 | 7,063 | 153,330 | 4,619 | 149,085 | 4,791 | | Hong Kong/Taiwan | 70,592 | 4,663 | 65,669 | 3,900 | 76,891 | 4,767 | | **Total** | **1,557,302** | **70,435** | **1,162,905** | **54,760** | **1,244,046** | **73,455** | - The business model in Mainland China is different from other markets due to local regulations, utilizing retail stores, sales employees, independent direct sellers, and independent marketers[29](index=29&type=chunk)[42](index=42&type=chunk) - Outside Mainland China, Brand Affiliates earn money through retail markups and sales compensation from their network's product sales (multi-level compensation)[39](index=39&type=chunk)[40](index=40&type=chunk) [Geographic Regions](index=12&type=section&id=GEOGRAPHIC%20REGIONS) Operating in approximately 50 markets, the company's revenue is segmented geographically, with Mainland China being the largest contributor in 2020 Revenue by Segment (2018-2020) | Segment | 2020 Revenue (Millions) | 2020 % | 2019 Revenue (Millions) | 2019 % | 2018 Revenue (Millions) | 2018 % | | :--- | :--- | :--- | :--- | :--- | :--- | :--- | | Mainland China | $625.5 | 24% | $722.5 | 30% | $886.5 | 33% | | Americas/Pacific | $511.9 | 20% | $349.1 | 14% | $385.0 | 14% | | South Korea | $326.5 | 13% | $330.0 | 14% | $373.4 | 14% | | Southeast Asia | $302.7 | 12% | $301.6 | 12% | $316.9 | 12% | | Japan | $273.7 | 10% | $260.0 | 11% | $254.9 | 10% | | EMEA | $230.2 | 9% | $167.2 | 7% | $182.4 | 7% | | Hong Kong/Taiwan | $161.1 | 6% | $166.3 | 7% | $185.9 | 7% | | Manufacturing | $149.3 | 6% | $121.9 | 5% | $90.6 | 3% | | **Total** | **$2,581.9** | **100%** | **$2,420.4** | **100%** | **$2,679.0** | **100%** | [Regulation](index=12&type=section&id=REGULATION) The company's direct selling model and products are subject to extensive global regulations, with particularly complex and restrictive frameworks in Mainland China - Direct selling regulations are intended to prevent pyramid schemes and generally require compensation to be based on product sales, not recruitment[54](index=54&type=chunk) - The regulatory environment in Mainland China is complex, prohibiting multi-level compensation and requiring a different business model, with no new direct selling licenses issued since early 2019[55](index=55&type=chunk) - Several markets, including Mainland China and South Korea, impose limits on the amount of sales compensation that can be paid (e.g., **30%** of revenue in China, **35%** of total value in South Korea)[58](index=58&type=chunk) - Products are regulated by agencies like the FDA, with cosmetics regulated for safety and labeling, and wellness products (dietary supplements) under DSHEA with specific rules for claims and new ingredients[61](index=61&type=chunk)[71](index=71&type=chunk) - The FTC exercises jurisdiction over advertising in the U.S. and has taken action against companies for deceptive advertising and lack of substantiation for claims, with the company having a consent decree from the early 1990s regarding product and earnings claims[84](index=84&type=chunk)[86](index=86&type=chunk) [Competition](index=19&type=section&id=COMPETITION) Nu Skin faces intense competition in direct selling and product markets from established global companies with greater financial resources and brand recognition - Competes with other direct selling organizations such as Amway, Avon Products, and Herbalife to attract and retain its sales force and consumers[92](index=92&type=chunk) - Product competitors include a broad array of marketers of personal care and nutritional products like L'Oréal, Clinique, Estée Lauder, and Mary Kay[93](index=93&type=chunk) [Human Capital Resources](index=19&type=section&id=HUMAN%20CAPITAL%20RESOURCES) As of year-end 2020, Nu Skin employed approximately 5,000 globally and 21,000 in Mainland China, with a human capital strategy focused on business transformation and diversity - As of year-end 2020, the company had approximately **5,000** full- and part-time employees globally, and an additional **21,000** sales employees in Mainland China[94](index=94&type=chunk) - The human capital strategy focuses on three objectives: supporting business transformation, leveraging diversity and inclusion, and simplifying the employee experience[95](index=95&type=chunk) - Recognized by Direct Selling News as one of the best places to work in direct selling for the fifth consecutive year in 2020[98](index=98&type=chunk) [Available Information](index=20&type=section&id=AVAILABLE%20INFORMATION) The company provides free access to its SEC filings and other material information on its Investor Relations website - SEC filings are available free of charge on the company's Investor Relations website, ir.nuskin.com[100](index=100&type=chunk) [Information About Our Executive Officers](index=21&type=section&id=INFORMATION%20ABOUT%20OUR%20EXECUTIVE%20OFFICERS) This section details executive officers as of January 2021, including a planned CEO transition for September 2021 - A CEO transition is planned for September 1, 2021, with current President Ryan S. Napierski set to succeed Ritch N. Wood as Chief Executive Officer[108](index=108&type=chunk) [Risk Factors](index=22&type=section&id=Item%201A.%20Risk%20Factors) The company faces substantial risks from direct selling model challenges, intense Mainland China scrutiny, competition, and cybersecurity threats - Challenges to the network marketing system, particularly from the FTC regarding pyramid schemes and improper earnings claims, pose a significant risk[113](index=113&type=chunk)[114](index=114&type=chunk)[115](index=115&type=chunk) - Operations in Mainland China are subject to intense government scrutiny and complex regulations that prohibit multi-level compensation, creating significant business risk[138](index=138&type=chunk)[143](index=143&type=chunk) - The business is dependent on its ability to recruit and retain its independent sales force, which is subject to high turnover[174](index=174&type=chunk) - The COVID-19 pandemic has negatively impacted the business by limiting in-person meetings, disrupting supply chains, and increasing regulatory scrutiny of health-related claims[161](index=161&type=chunk)[163](index=163&type=chunk) - Cybersecurity risks and failure to protect customer and sales force data could lead to litigation, liability, and reputational harm, especially with evolving data privacy laws like GDPR[236](index=236&type=chunk)[237](index=237&type=chunk) [Unresolved Staff Comments](index=44&type=section&id=Item%201B.%20Unresolved%20Staff%20Comments) The company reports no unresolved staff comments - None[242](index=242&type=chunk) [Properties](index=45&type=section&id=Item%202.%20Properties) The company's principal properties include corporate headquarters, R&D centers, and manufacturing facilities primarily in Utah and Mainland China - Principal administrative offices are in Provo, Utah and Shanghai, China[244](index=244&type=chunk) - The company operates its own manufacturing facilities in Mainland China and, through its Rhyz arm, in Utah[246](index=246&type=chunk) [Legal Proceedings](index=45&type=section&id=Item%203.%20Legal%20Proceedings) The company is in ongoing litigation with Don Roberts over a claimed **50%** ownership in its indoor-growing business, seeking over **$250 million** - The company is in litigation with Don Roberts, who claims a **50%** ownership interest in the indoor-growing business and is seeking damages exceeding **$250 million**[247](index=247&type=chunk) [Mine Safety Disclosures](index=45&type=section&id=Item%204.%20Mine%20Safety%20Disclosures) This item is not applicable to the company - Not applicable[248](index=248&type=chunk) Part II [Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities](index=46&type=section&id=Item%205.%20Market%20for%20Registrant's%20Common%20Equity%2C%20Related%20Stockholder%20Matters%20and%20Issuer%20Purchases%20of%20Equity%20Securities) The company's Class A common stock trades on the NYSE under 'NUS', with **325,479** shares repurchased for approximately **$17 million** in Q4 2020 Issuer Purchases of Equity Securities (Q4 2020) | Period | Total Shares Purchased | Average Price Paid per Share | Approx. Dollar Value Remaining Under Plan (millions) | | :--- | :--- | :--- | :--- | | Oct 1 – 31, 2020 | 60,985 | $54.12 | $339.5 | | Nov 1 – 30, 2020 | 142,954 | $51.36 | $332.2 | | Dec 1 – 31, 2020 | 121,540 | $52.09 | $325.8 | | **Total** | **325,479** | **$52.15** | **$325.8** | - The company's Class A common stock is listed on the NYSE under the symbol 'NUS'[250](index=250&type=chunk) [Reserved](index=47&type=section&id=Item%206.%20Reserved) This item is not applicable [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=48&type=section&id=Item%207.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) In 2020, revenue grew **7%** to **$2.58 billion**, driven by digital commerce and customer growth, despite a decline in Mainland China [Results of Operations](index=52&type=section&id=Results%20of%20Operations) For 2020, revenue increased **7%** to **$2.58 billion**, driven by Americas/Pacific and EMEA growth, offsetting a Mainland China decline, while gross margin decreased 2020 vs. 2019 Revenue Change by Segment | Segment | 2020 Revenue (millions) | 2019 Revenue (millions) | % Change | Constant Currency % Change | | :--- | :--- | :--- | :--- | :--- | | Mainland China | $625.5 | $722.5 | (13)% | (14)% | | Americas/Pacific | $511.9 | $349.1 | 47% | 53% | | South Korea | $326.5 | $330.0 | (1)% | — | | Southeast Asia | $302.7 | $301.6 | — | 1% | | Japan | $273.7 | $260.0 | 5% | 3% | | EMEA | $230.2 | $167.2 | 38% | 35% | | Hong Kong/Taiwan | $161.1 | $166.3 | (3)% | (6)% | | **Total Nu Skin** | **$2,431.7** | **$2,298.4** | **6%** | **6%** | - Overall revenue increased **7%** to **$2.58 billion** in 2020 from **$2.42 billion** in 2019[286](index=286&type=chunk) - Diluted earnings per share increased **17%** to **$3.63** in 2020 from **$3.10** in 2019, driven by higher revenue, a lower tax rate, and stock repurchases[288](index=288&type=chunk) - Gross profit as a percentage of revenue decreased to **74.5%** in 2020 from **76.0%** in 2019, primarily due to higher freight costs and shifts in product and geographic mix[307](index=307&type=chunk) [Liquidity and Capital Resources](index=57&type=section&id=Liquidity%20and%20Capital%20Resources) The company's liquidity remains strong, with cash from operations increasing to **$379.1 million** in 2020, supporting dividends, repurchases, and capital expenditures - Generated **$379.1 million** in cash from operations in 2020, a significant increase from **$177.9 million** in 2019[315](index=315&type=chunk) - Ended 2020 with **$423.9 million** in cash and cash equivalents, up from **$344.0 million** in 2019[316](index=316&type=chunk) - In 2020, the company repurchased **5.1 million** shares for **$144.3 million** and paid **$78.4 million** in dividends[322](index=322&type=chunk)[323](index=323&type=chunk) - As of Dec 31, 2020, the company had **$337.5 million** outstanding on its term loan and no borrowings under its **$350 million** revolving credit facility[321](index=321&type=chunk) [Critical Accounting Policies and Estimates](index=51&type=section&id=Critical%20Accounting%20Policies%20and%20Estimates) Management identifies Income Taxes and Intangible Assets as critical accounting policies, requiring significant judgment in valuation and impairment testing - The company's critical accounting policies are identified as Accounting for Income Taxes and Accounting for Intangible Assets[275](index=275&type=chunk) - As of December 31, 2020, the company had net deferred tax assets of **$34.8 million** and unrecognized tax benefits of **$17.6 million**[276](index=276&type=chunk)[280](index=280&type=chunk) - Goodwill and indefinite-lived intangible assets are tested for impairment annually; no impairment charges were recognized in 2020, 2019, or 2018[283](index=283&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=59&type=section&id=Item%207A.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company is exposed to foreign currency and interest rate risks, managing the latter with interest rate swaps and monitoring the LIBOR transition - A majority of revenue is from outside the U.S., exposing the company to foreign currency risk, where a strengthening U.S. dollar negatively impacts reported revenue and earnings[331](index=331&type=chunk) - The company is exposed to interest rate risk on its variable-rate debt; as of Dec 31, 2020, a hypothetical **1%** increase in rates would increase annual interest expense by about **$1.4 million**[336](index=336&type=chunk) - The company uses interest rate swaps to hedge variable cash flows associated with its variable-rate debt, with a total notional amount of **$200 million** as of year-end 2020[322](index=322&type=chunk)[336](index=336&type=chunk) - The company is monitoring the planned phase-out of LIBOR, which is the reference rate for its credit facility and interest rate swaps[338](index=338&type=chunk) [Financial Statements and Supplementary Data](index=61&type=section&id=Item%208.%20Financial%20Statements%20and%20Supplementary%20Data) This section presents the company's audited consolidated financial statements for fiscal year 2020, including balance sheets, income statements, and cash flow statements Consolidated Balance Sheet Data (as of Dec 31) | (in thousands) | 2020 | 2019 | | :--- | :--- | :--- | | **Total Assets** | **$1,957,076** | **$1,769,006** | | Total Current Assets | $903,198 | $740,166 | | **Total Liabilities** | **$1,062,805** | **$893,717** | | Total Current Liabilities | $542,856 | $356,760 | | Long-term Debt | $305,393 | $334,461 | | **Total Stockholders' Equity** | **$894,271** | **$875,289** | Consolidated Income Statement Data (Year Ended Dec 31) | (in thousands, except per share) | 2020 | 2019 | 2018 | | :--- | :--- | :--- | :--- | | Revenue | $2,581,934 | $2,420,416 | $2,679,008 | | Gross Profit | $1,923,906 | $1,838,996 | $2,044,868 | | Operating Income | $257,564 | $267,426 | $240,860 | | **Net Income** | **$191,355** | **$173,553** | **$121,887** | | Diluted EPS | $3.63 | $3.10 | $2.16 | Consolidated Cash Flow Data (Year Ended Dec 31) | (in thousands) | 2020 | 2019 | 2018 | | :--- | :--- | :--- | :--- | | Net cash provided by operating activities | $379,141 | $177,931 | $202,738 | | Net cash used in investing activities | ($79,428) | ($71,412) | ($108,761) | | Net cash used in financing activities | ($245,166) | ($154,794) | ($116,714) | | **Net increase (decrease) in cash** | **$67,053** | **($51,281)** | **($39,488)** | [Changes in and Disagreements with Accountants on Accounting and Financial Disclosure](index=103&type=section&id=Item%209.%20Changes%20in%20and%20Disagreements%20with%20Accountants%20on%20Accounting%20and%20Financial%20Disclosure) The company reports no changes in or disagreements with its accountants on accounting and financial disclosure - None[532](index=532&type=chunk) [Controls and Procedures](index=103&type=section&id=Item%209A.%20Controls%20and%20Procedures) Management concluded that disclosure controls and internal control over financial reporting were effective as of December 31, 2020 - Management concluded that disclosure controls and procedures were effective as of December 31, 2020[533](index=533&type=chunk) - Management concluded that internal control over financial reporting was effective as of December 31, 2020[535](index=535&type=chunk) [Other Information](index=103&type=section&id=Item%209B.%20Other%20Information) The company reports no other information for this item - None[536](index=536&type=chunk) Part III [Directors, Executive Officers, Corporate Governance, Executive Compensation, Security Ownership, and Certain Relationships](index=104&type=section&id=ITEMS%2010-14) Information for these items will be incorporated by reference from the forthcoming 2021 Definitive Proxy Statement - Information for Items 10, 11, 12, 13, and 14 is incorporated by reference from the forthcoming 2021 Definitive Proxy Statement[538](index=538&type=chunk) Part IV [Exhibits and Financial Statement Schedules](index=104&type=section&id=Item%2015.%20Exhibits%20and%20Financial%20Statement%20Schedules) This section lists documents filed as part of the Form 10-K, including financial statements and various corporate exhibits [Form 10-K Summary](index=106&type=section&id=Item%2016.%20Form%2010-K%20Summary) The company reports no summary for this item - None[545](index=545&type=chunk)
Nu Skin(NUS) - 2020 Q3 - Quarterly Report
2020-11-05 01:33
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Title of each class Trading Symbol(s) Name of each exchange on which registered Class A Common Stock, $.001 par value NUS New York Stock Exchange FORM 10-Q ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM _____________ TO ____ ...